Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Connor

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Annals of the New York Academy of Sciences|March 6, 2004
Aggressive behavior in abused childrenDaniel F Connor, Leonard A Doerfler, Adam M Volungis, et al.
The Yale Journal of Biology and Medicine|June 15, 2013
Late-life onset bipolar disorder presenting as a case of pseudo-dementia: a case discussion and review of literatureAlok Banga, Tsewang Gyurmey, David Matuskey, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 25, 2003
Correlates of comorbid psychopathology in children with ADHDDaniel F Connor, Gwenyth Edwards, Kenneth E Fletcher, et al.
Journal of Child and Adolescent Psychopharmacology|December 20, 2016
Challenges in the Psychopharmacological Management of Very Early-Onset Schizophrenia and AnxietyAskar Mehdi, Brian C Schweinsburg, Asima Zehgeer, et al.
CNS Drugs|September 3, 2010
Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trialDaniel F Connor, Robert L Findling, Scott H Kollins, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|April 7, 2018
Practitioner Review: Emotional dysregulation in attention-deficit/hyperactivity disorder - implications for clinical recognition and interventionStephen V Faraone, Anthony L Rostain, Joseph Blader, et al.
Journal of Child and Adolescent Psychopharmacology|December 17, 2014
Single-dose pharmacokinetics of methylphenidate extended-release multiple layer beads administered as intact capsule or sprinkles versus methylphenidate immediate-release tablets (Ritalin(®)) in healthy adult volunteersAkwete Adjei, Nathan S Teuscher, Robert J Kupper, et al.
Clinical Pediatrics|August 8, 2006
Targeted child psychiatric services: a new model of pediatric primary clinician--child psychiatry collaborative careDaniel F Connor, Thomas J McLaughlin, Mary Jeffers-Terry, et al.
Clinical Therapeutics|June 6, 2006
Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation studyThomas J Spencer, Howard B Abikoff, Daniel F Connor, et al.
Pediatrics|November 23, 2011
Antipsychotic medication use among children and risk of diabetes mellitusSusan E Andrade, Joan C Lo, Douglas Roblin, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Annals of the New York Academy of Sciences|March 6, 2004
Aggressive behavior in abused childrenDaniel F Connor, Leonard A Doerfler, Adam M Volungis, et al.
The Yale Journal of Biology and Medicine|June 15, 2013
Late-life onset bipolar disorder presenting as a case of pseudo-dementia: a case discussion and review of literatureAlok Banga, Tsewang Gyurmey, David Matuskey, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 25, 2003
Correlates of comorbid psychopathology in children with ADHDDaniel F Connor, Gwenyth Edwards, Kenneth E Fletcher, et al.
Journal of Child and Adolescent Psychopharmacology|December 20, 2016
Challenges in the Psychopharmacological Management of Very Early-Onset Schizophrenia and AnxietyAskar Mehdi, Brian C Schweinsburg, Asima Zehgeer, et al.
CNS Drugs|September 3, 2010
Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trialDaniel F Connor, Robert L Findling, Scott H Kollins, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|April 7, 2018
Practitioner Review: Emotional dysregulation in attention-deficit/hyperactivity disorder - implications for clinical recognition and interventionStephen V Faraone, Anthony L Rostain, Joseph Blader, et al.
Journal of Child and Adolescent Psychopharmacology|December 17, 2014
Single-dose pharmacokinetics of methylphenidate extended-release multiple layer beads administered as intact capsule or sprinkles versus methylphenidate immediate-release tablets (Ritalin(®)) in healthy adult volunteersAkwete Adjei, Nathan S Teuscher, Robert J Kupper, et al.
Clinical Pediatrics|August 8, 2006
Targeted child psychiatric services: a new model of pediatric primary clinician--child psychiatry collaborative careDaniel F Connor, Thomas J McLaughlin, Mary Jeffers-Terry, et al.
Clinical Therapeutics|June 6, 2006
Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation studyThomas J Spencer, Howard B Abikoff, Daniel F Connor, et al.
Pediatrics|November 23, 2011
Antipsychotic medication use among children and risk of diabetes mellitusSusan E Andrade, Joan C Lo, Douglas Roblin, et al.
Pageof 8